BVX 0320
Alternative Names: BVX-0320; SARS-CoV-2 Vaccine - BioVaxysLatest Information Update: 18 Feb 2022
At a glance
- Originator BioVaxys
- Class COVID-19 vaccines; Protein vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections